GIVE Generics A Break: FDA Review Plan Draws Grumbles From Industry
Executive Summary
FDA's announcement about its new review procedures for generic drugs may well be tailored to have more impact on congressional appropriations committees than on the ANDAs themselves
You may also be interested in...
Congress Spars With FDA On Budget Figures And Scientific Readiness
Any significant increase to FDA's 2009 budget may require more active involvement by the agency to restructure and recruit personnel than it has shown to date
Congress Spars With FDA On Budget Figures And Scientific Readiness
Any significant increase to FDA's 2009 budget may require more active involvement by the agency to restructure and recruit personnel than it has shown to date
FDA Proposes Bioequivalence Research On Inhalers, Other Complex Drugs
FDA is recommending specific research projects that will help demonstrate the bioequivalence of generic versions of complex branded products